Femoral artery stent LIFESTENT® 5F

femoral artery stent
femoral artery stent
femoral artery stent
Add to favorites
Compare this product


femoral artery


Features Unique helical design engineered for bending, compression, torsion Only stent FDA-approved for the SFA and full popliteal artery1 Low profile, 5F delivery system Dual-speed thumbwheel deployment designed for ease of use and placement accuracy2 GEOALIGN® Marking System designed to increase procedural efficiency and reduce radiation exposure3 Clinically Proven Stent Design: As the only commercially available stent FDA-approved for the superficial femoral and full popliteal artery, the LIFESTENT® Vascular Stent has a history of proven performance: In a Level 1 RESILIENT study, the LIFESTENT® Vascular Stent demonstrated treatment superiority over balloon angioplasty with sustained effectiveness out to 3 years4 In the investigator initiated, Level 1 ETAP study of the popliteal artery the LIFESTENT® Vascular Stent demonstrated double the primary patency rate of PTA out to two years5 In a clinical assessment of the treatment of long lesions, the LIFESTENT® Vascular Stent demonstrated high primary patency at 12 months in lesions up to 240mm6 The LIFESTENT® Vascular Stent Systems, in varying sizes, have been studied in more than ten clinical trials globally.Low Profile, 5F Delivery System: The LIFESTENT® 5F Vascular Stent System offers the same clinically-proven advanced helical stent design as the LIFESTENT® Vascular Stent on a low profile, 5F delivery system. The LIFESTENT® 5F delivery system offers dual speed thumbwheel deployment with a tri-axial catheter that is designed for ease of use, deployment control, and precise placement accuracy


No catalogs are available for this product.

See all of Bard Medical‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.